Results 181 to 190 of about 19,031 (203)

On the Mechanism of Inhibition of KATPChannels by Glibenclamide in Rat Ventricular Myocytes

Journal of Cardiovascular Electrophysiology, 1993
Cristina Ripoll, W J Lederer, Colin G Nichols   +2 more
exaly  

The effect of gliclazide and glibenclamide on preconditioning of the human myocardium

European Journal of Pharmacology, 2005
Mahmoud Loubani, Nicholas B Standen
exaly  

Glibenclamide ameliorates the disrupted blood–brain barrier in experimental intracerebral hemorrhage by inhibiting the activation of NLRP3 inflammasome

Brain and Behavior, 2019
Fulin Xu, Zuopeng Su
exaly  

The Antidiabetic Agent Glibenclamide Protects Airway Hyperresponsiveness and Inflammation in Mice

Inflammation, 2014
Wei Cui, Shufang Zhang, Zhijian Cai
exaly  

Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients

European Journal of Clinical Pharmacology, 2011
Aparna Agrawal, D K S Subrahmanyam, Chandrasekaran Adithan   +2 more
exaly  

Glibenclamide

Reactions Weekly, 2004
openaire   +1 more source

Glibenclamide

Reactions Weekly, 2021
openaire   +1 more source

Optimization and evaluation of zein nanoparticles to improve the oral delivery of glibenclamide. In vivo study using C. elegans

European Journal of Pharmaceutics and Biopharmaceutics, 2017
David Lucio, Maria Cristina Martínez-Ohárriz, Paula Aranaz   +2 more
exaly  

Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides

British Journal of Pharmacology, 2002
Annette Hambrock, Cornelia Löffler-Walz, Ulrich Quast   +2 more
exaly  

A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes

Nutrition, Metabolism and Cardiovascular Diseases, 2007
Markolf Hanefeld, Nigel P Jones
exaly